Rchr
J-GLOBAL ID:200901015381162147   Update date: May. 29, 2020

Nabeshima Toshitaka

ナベシマ トシタカ | Nabeshima Toshitaka
Affiliation and department:
Job title: Professor
Homepage URL  (1): http://www.med.nagoya-u.ac.jp/pharmacy/
Research field  (3): Pharmacology ,  Pharmaceuticals - health and biochemistry ,  Neuroscience - general
Research keywords  (2): Neurochemistry and Neuropharmacology ,  Biopharmacology
Research theme for competitive and other funds  (3):
  • Role of NMDA and Sigma receptors in central nervous system
  • Mechanism of drug dependence
  • Development of Alzheimer's disease animal model
MISC (159):
Books (2):
  • Cogntive enhancing effects of nefiractam.
    New Drug Development in Japan, 1996
  • Carbon monoxide-induced impairment of learning, memory and neuronal dysfunction.
    in "Carbon Monoxide ", Ed. by D. G. Penney,CRC Press Inc, Chapter g 1996
Education (3):
  • - 1973 Osaka University Graduate School, Division of Pharmaceutical Sciences
  • - 1968 Gifu Pharmaceutical University Faculty of Pharmaceutical Science Department of Manufacturing Pharmacy
  • - 1968 Gifu Pharmaceutical University Faculty of Pharmaceutical Science
Professional career (1):
  • Ph. D., Pharmacology (Tohoku University)
Awards (7):
  • 2001 - Award of Aichi Prefectural Society of Hospital Pharmacists
  • 1999 - Professor emeritus of "Alexandru Ioan Cuza" University, Rumania
  • 1999 - Research Award of Society of Hospital Pharmacists
  • 1995 - Research Award of Pharmaceutical Society of Japan
  • 1994 - Research Award of Japanese Society of Neuropsychopharmacology
Show all
Association Membership(s) (48):
The Canadian College of Neuropsychopharmacology(CCNP) ,  5th International Conference on Progress in Alzheimer's and Parkinson's Disease ,  9th International Catecholamine Symposium ,  Japan-Korea Joint Seminar on Pharmacology ,  Federation International Pharmacetique(FIP) ,  Collegium International Neuro-Psychopharmacologium(CINP) ,  Federation of American Societies for Experimental Biology ,  The American Society for Pharmacology and Experimental Therapeutics ,  International Brain Research Organization ,  Society for Neuroscience ,  The Japanese Society for Hospital Pharmacy ,  Tokai Cerebral Circulaion and Metabolism Study Group ,  Symposium for Molecular Monitoring in the field of Neuroscience ,  Forum on Health for Children in Aichi in the 21st century ,  The Japanese Society for the Study of Xenobiotics ,  Tokai Chinese Medicine Study Group ,  Tokai Cancer Clinical Pharmacy Seminar ,  Sigma Receptor Study Group ,  Tokai Clinical Pharmaceutical Practice Study Group ,  Tokai Drug Therapy Study Group ,  24th General Assembly of the Japan Medical Congress ,  Forum on Nicotine and Chemical Dependency ,  Society for Neuropsychopharmacology ,  Neurotransmitter and Disease Study Group ,  Gerontological Disease and Prostaglandin Study Group ,  Japan Brain Science Society ,  Japanese Society for Surgical Metabolism and Nutrition ,  Japanese Stomatological Society ,  Japanese Society of Gerontology ,  Japanese Society of Allergology ,  Forum for Drug Development ,  Japan Neuroscience Society ,  Japanese Society of Clinical Pharmacology and Therapeutics ,  Japanese Society of Pharmaceutical Health Care and Sciences(Former Hospital Pharmaceutical Society of Japan) ,  The Aichi Pharmaceutical Association ,  The Aichi Prefectural Society of Hospital Pharmacists ,  The Japan Pharmaceutical Association ,  Japanese Society of Hospital Pharmacists ,  Conference on Medicine and Biology of the Brain ,  Japanese Society of Biological Psychiatry ,  The Japanese Society for the Study of Pain ,  The Japanese Society of Toxicological Sciences ,  The Japanese Society of Pharmacometrics ,  The Japanese Society of Neuropsychopharmacology ,  The Japanese Pharmacological Society ,  The Japanese Neurochemical Society ,  The Pharmaceutical Society of Japan ,  The Japanese Biochemical Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page